ELOXX PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$13.45
+1.89%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-14.4%
3 months
-27.1%
6 months
+543.5%
1 year
+1344900.0%
Year to date
+1344900.0%
52-week range
$0.00 – $20.98
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$54.3M
P/E
-9.1
P/B
1.2
P/S
—
Revenue
—
Net income
—
Diluted EPS
—
Gross margin
—
Net margin
—
Return on equity
—
Total debt
$11.83M
Cash
$61.97M
Free cash flow
—
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$4.5M | — | — | -$4.79M |
| Mar 31, 2026 | $0 | -$3.75M | — | — | -$5.45M |
| Mar 31, 2026 | $0 | -$3.75M | — | — | -$5.45M |
| Dec 31, 2025 | — | — | — | — | — |
| Sep 30, 2023 | $0 | -$3.59M | — | — | -$3.22M |
| Jun 30, 2023 | $0 | -$4.34M | — | — | -$2.05M |
| Mar 31, 2023 | $0 | -$6.23M | — | — | -$6.8M |
| Dec 31, 2022 | $0 | -$6.32M | — | — | -$5.66M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ELOX news
All market newsNo ticker-linked stories are in the current archive.